Applied Micro Circuits downgraded to Market Perform at FBR Capital FBR Capital downgraded Applied Micro Circuits to Market Perform from Outperform citing weakness in the company's core business. The firm also believes consensus estimates for X-Gene's revenue contribution are too optimistic. FBR lowered its price target for shares to $10 from $11.
News For AMCC From The Last 14 Days
Check below for free stories on AMCC the last two weeks.